Although Heeschen and colleagues have revealed that Nodal/Activin signaling drives the self-renewal and tumorigenicity of pancreatic cancer stem cells (CSCs), CSCs are a rare subpopulation, accounting for only 0.2–0.8% of pancreatic cancer cells [21, 22]. The gene discussed is NODAL; the disease is familial pancreatic carcinoma.